Key Statistics
Market Cap$1.85B
P/E RatioN/A
Div. Yield—
EPS (TTM)-$1.42
52W High$16.44
52W Low$5.80
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees325
Price Performance
1 Week+14.73%
3 Month-26.49%
1 Year+34.76%
FinancialsAnnual · QuiverQuant
Revenue$58.44M
Assets$252.06M
Liabilities$160.93M
Net Income$80.74M loss
About
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology. The company is headquartered in Bedford, Massachusetts.
WebullFree stocks
Advanced charting, extended hours trading, and free stock for new accounts.
Analyze OCUL with professional charts— Free to start
Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.